Cited by 186Curcumin's Biomedical ApplicationsParaoxonase enzyme and polymorphismsNatural Products and Biological Research

Effects of curcumin on HDL functionality

Open access
Ganjali, Shiva, Blesso, Christopher N., Banach, Maciej, Pirro, Matteo, Majeed, Muhammed, Sahebkar, Amirhossein·2017·Pharmacological Research

Abstract

Curcumin, a bioactive polyphenol, is a yellow pigment of the Curcuma longa (turmeric) plant. Curcumin has many pharmacologic effects including antioxidant, anti-carcinogenic, anti-obesity, anti-angiogenic and anti-inflammatory properties. Recently, it has been found that curcumin affects lipid metabolism, and subsequently, may alleviate hyperlipidemia and atherosclerosis. Plasma HDL cholesterol (HDL-C) is an independent negative risk predictor of cardiovascular disease (CVD). However, numerous clinical and genetic studies have yielded disappointing results about the therapeutic benefit of raising plasma HDL-C levels. Therefore, research efforts are now focused on improving HDL functionality, independent of HDL-C levels. The quality of HDL particles can vary considerably due to heterogeneity in composition. Consistent with its complexity in composition and metabolism, a wide range of biological activities is reported for HDL, including antioxidant, anti-glycation, anti-inflammatory, anti-thrombotic, anti-apoptotic and immune modulatory activities. Protective properties of curcumin may influence HDL functionality; therefore, we reviewed the literature to determine whether curcumin can augment HDL function. In this review, we concluded that curcumin may modulate markers of HDL function, such as apo-AI, CETP, LCAT, PON1, MPO activities and levels. Curcumin may subsequently improve conditions in which HDL is dysfunctional and may have potential as a therapeutic drug in future. Further clinical trials with bioavailability-improved formulations of curcumin are warranted to examine its effects on lipid metabolism and HDL function.

Integrity signals

Registry

Crossref · 10.1016/j.phrs.2017.02.008

Cites

126 of 126 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Curcumin may modulate HDL production and HDL functionality biomarkers, including apolipoprotein AI, cholesteryl ester transfer protein, lecithin cholesterol acyl transferase, paraoxonase-1, myeloperoxidase, and lipoprotein-associated phospholipase A2.

    “Curcumin may also modulate the production of HDL and biomarkers of HDL functionality, including apolipoprotein AI ([), cholesteryl ester transfer protein (Y), lecithin cholesterol acyl transferase ([), paraoxonase-1 (Y), myeloperoxidase (Y), and lipoprotein-associated phospholipase A2 (Y) (174-177).”

    From The Role of Nutraceuticals in Statin Intolerant Patients (2018) · cites this paper as [174]

Cites

Flagged first, then by citations

7 of the 133 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Ganjali, S., Blesso, C. N., Banach, M., Pirro, M., Majeed, M., & Sahebkar, A.
Affiliations
  • Mashhad University of Medical Sciences (IR)
  • University of Connecticut (US)
  • Medical University of Lodz (PL)
  • University of Perugia (IT)
Corresponding author
Sahebkar, Amirhossein
Venue
Pharmacological Research
Publisher
Elsevier BV
Published
2017-05
Volume
119
Pages
208-218
ISSN
1043-6618 (ISSN-L)
OpenAlex
W2586622953
Cited by
186
References
133
Citations by year
2026: 6 · 2025: 19 · 2024: 8 · 2023: 24 · 2022: 20 · 2021: 16 · 2020: 11 · 2019: 27 · 2018: 35 · 2017: 20
FWCI
1.64
Type
journal article
Language
en
Open access
Locations
  • Pharmacological Research (publishedVersion)
  • PubMed (publishedVersion)
  • UWA Profiles and Research Repository (UWA) (submittedVersion)
  • Figshare (submittedVersion, cc-by)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Medicine › Curcumin's Biomedical Applications
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Paraoxonase enzyme and polymorphisms
  • Health Sciences › Medicine › Surgery › Natural Products and Biological Research
Keywords
curcumin, HDL function, HDL cholesterol, HDL dysfunction, apolipoprotein A-I, cholesteryl ester transfer protein, lecithin:cholesterol acyltransferase, paraoxonase 1, myeloperoxidase, lipid metabolism, hyperlipidemia, atherosclerosis, cardiovascular disease, polyphenols, bioavailability
MeSH terms
Animals, Anti-Inflammatory Agents, Non-Steroidal, Antioxidants, Curcumin, Humans, Lipoproteins, HDL, Curcuma, Dyslipidemias, Atherosclerosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review